Gene · 489
Papers2,442
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,442
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Uncovering NOTCH1 as a Promising Target in the Treatment of MLL-Rearranged Leukemia. | Int J Mol Sci | 2023 | 37833915 | PubTator, text mining | PubMed |
| Polyarginine Cell-Penetrating Peptides Bind and Inhibit SERCA2. | Cells | 2023 | 37830576 | PubTator, text mining | PubMed |
The Integrated Bioinformatic Assay of Genetic Expression Features and Analyses of Traditional Chinese Medicine Specific Constitution Reveal Metabolic Characteristics and Targets in Steatosis of Nonalcoholic Fatty Liver Disease. | Hepat Med | 2023 | 37822344 | PubTator, text mining | PubMed |
| Comprehensive review on the pathogenesis of hypertriglyceridaemia-associated acute pancreatitis. | Ann Med | 2023 | 37813108 | PubTator, text mining | PubMed |
| Intracellular FGF1 protects cells from apoptosis through direct interaction with p53. | Cell Mol Life Sci | 2023 | 37783936 | PubTator, text mining | PubMed |
| A multiple-oscillator mechanism underlies antigen-induced Ca2+ oscillations in Jurkat T-cells. | J Biol Chem | 2023 | 37778728 | PubTator, text mining | PubMed |
| SARS-CoV-2 Syncytium under the Radar: Molecular Insights of the Spike-Induced Syncytia and Potential Strategies to Limit SARS-CoV-2 Replication. | J Clin Med | 2023 | 37763019 | PubTator, text mining | PubMed |
| Positive Allosteric Modulators of SERCA Pump Restore Dendritic Spines and Rescue Long-Term Potentiation Defects in Alzheimer's Disease Mouse Model. | Int J Mol Sci | 2023 | 37762276 | PubTator, text mining | PubMed |
| Pollutants, including Organophosphorus and Organochloride Pesticides, May Increase the Risk of Cardiac Remodeling and Atrial Fibrillation: A Narrative Review. | Biomedicines | 2023 | 37760868 | PubTator, text mining | PubMed |
| Towards Improved Human In Vitro Models for Cardiac Arrhythmia: Disease Mechanisms, Treatment, and Models of Atrial Fibrillation. | Biomedicines | 2023 | 37760796 | PubTator, text mining | PubMed |
| AQP4-independent TRPV4 modulation of plasma membrane water permeability. | Front Cell Neurosci | 2023 | 37720545 | PubTator, text mining | PubMed |
| Translocation of IGF-1R in endoplasmic reticulum enhances SERCA2 activity to trigger Ca2+ER perturbation in hepatocellular carcinoma. | Acta Pharm Sin B | 2023 | 37719369 | PubTator, text mining | PubMed |
| Targeting host calcium channels and viroporins: a promising strategy for SARS-CoV-2 therapy. | Future Virol | 2023 | 37700758 | PubTator, text mining | PubMed |
| The Ca2+ channel ORAI1 is a regulator of oral cancer growth and nociceptive pain. | Sci Signal | 2023 | 37669398 | PubTator, text mining | PubMed |
| Determinants of the maximal functional reserve during repeated supramaximal exercise by humans: The roles of Nrf2/Keap1, antioxidant proteins, muscle phenotype and oxygenation. | Redox Biol | 2023 | 37666117 | PubTator, text mining | PubMed |
| Tumor-associated macrophages confer colorectal cancer 5-fluorouracil resistance by promoting MRP1 membrane translocation via an intercellular CXCL17/CXCL22-CCR4-ATF6-GRP78 axis. | Cell Death Dis | 2023 | 37658050 | PubTator, text mining | PubMed |
| YTnC2, an improved genetically encoded green calcium indicator based on toadfish troponin C. | FEBS Open Bio | 2023 | 37650870 | PubTator, text mining | PubMed |
| Store-Operated Ca2+ Entry as a Putative Target of Flecainide for the Treatment of Arrhythmogenic Cardiomyopathy. | J Clin Med | 2023 | 37629337 | PubTator, text mining | PubMed |
| The Unfolded Protein Response: A Double-Edged Sword for Brain Health. | Antioxidants (Basel) | 2023 | 37627643 | PubTator, text mining | PubMed |
| The anoikis-related gene signature predicts survival accurately in colon adenocarcinoma. | Sci Rep | 2023 | 37626132 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/489/papers?page=7